Author

Sylvia Quesada

Institutions: Stanford Medicine, Stanford University

Observed institutions: Stanford Medicine, Stanford University

OpenAlex ID: A5082585348

A Phase II intra‐patient dose‐escalation trial of weight‐based darbepoetin alfa with or without granulocyte‐colony stimulating factor in myelodysplastic syndromes

2008 · Jason Gotlib, Philip Lavori, et al. · American Journal of Hematology · 40

Phase II Trial of Darbepoetin Alfa in Myelodysplastic Syndrome (MDS): Preliminary Efficacy, Safety, and In Vitro Results.

2004 · Jason Gotlib, Sylvia Quesada, et al. · Blood · 8

Phase II Trial of the Tyrosine Kinase Inhibitor PKC412 in Advanced Systemic Mastocytosis: Preliminary Results.

2006 · Jason Gotlib, Tracy I. George, et al. · Blood · 4

Works count: 3

Citation count: 52

H-index: 3

I10-index: 1